nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—Etoposide—sarcoma	0.154	0.289	CbGbCtD
Montelukast—CYP3A4—Thiotepa—sarcoma	0.133	0.249	CbGbCtD
Montelukast—CYP2C8—Etoposide—sarcoma	0.0887	0.167	CbGbCtD
Montelukast—CYP3A4—Mitoxantrone—sarcoma	0.0571	0.107	CbGbCtD
Montelukast—CYP3A4—Vincristine—sarcoma	0.0393	0.0738	CbGbCtD
Montelukast—CYP3A4—Etoposide—sarcoma	0.036	0.0676	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—sarcoma	0.0245	0.0461	CbGbCtD
Montelukast—CYSLTR1—hematopoietic system—sarcoma	0.00606	0.0629	CbGeAlD
Montelukast—CYSLTR1—smooth muscle tissue—sarcoma	0.00534	0.0554	CbGeAlD
Montelukast—SLCO2B1—mammary gland—sarcoma	0.00464	0.0482	CbGeAlD
Montelukast—CYSLTR1—uterus—sarcoma	0.00458	0.0475	CbGeAlD
Montelukast—CYSLTR1—lymphoid tissue—sarcoma	0.00427	0.0443	CbGeAlD
Montelukast—CYSLTR1—bone marrow—sarcoma	0.00389	0.0403	CbGeAlD
Montelukast—ALOX5—hematopoietic system—sarcoma	0.00367	0.0381	CbGeAlD
Montelukast—ALOX5—connective tissue—sarcoma	0.00354	0.0367	CbGeAlD
Montelukast—CYP2A6—seminal vesicle—sarcoma	0.00341	0.0354	CbGeAlD
Montelukast—ALOX5—smooth muscle tissue—sarcoma	0.00323	0.0336	CbGeAlD
Montelukast—PTGS1—endothelium—sarcoma	0.003	0.0312	CbGeAlD
Montelukast—CYP2C8—mammary gland—sarcoma	0.00298	0.031	CbGeAlD
Montelukast—SLCO2B1—hematopoietic system—sarcoma	0.00283	0.0293	CbGeAlD
Montelukast—CYP2C9—mammary gland—sarcoma	0.00265	0.0275	CbGeAlD
Montelukast—ALOX5—lymphoid tissue—sarcoma	0.00259	0.0268	CbGeAlD
Montelukast—CYSLTR1—lymph node—sarcoma	0.00241	0.025	CbGeAlD
Montelukast—ALOX5—bone marrow—sarcoma	0.00235	0.0244	CbGeAlD
Montelukast—SLCO2B1—uterus—sarcoma	0.00214	0.0222	CbGeAlD
Montelukast—ALOX5—testis—sarcoma	0.00201	0.0209	CbGeAlD
Montelukast—ALOX5—liver—sarcoma	0.0019	0.0197	CbGeAlD
Montelukast—SLCO2B1—tendon—sarcoma	0.00187	0.0194	CbGeAlD
Montelukast—CYP2C8—hematopoietic system—sarcoma	0.00182	0.0189	CbGeAlD
Montelukast—CYP2A6—liver—sarcoma	0.00168	0.0174	CbGeAlD
Montelukast—CYP2C9—hematopoietic system—sarcoma	0.00161	0.0168	CbGeAlD
Montelukast—PTGS1—seminal vesicle—sarcoma	0.00155	0.0161	CbGeAlD
Montelukast—SLCO2B1—testis—sarcoma	0.00155	0.0161	CbGeAlD
Montelukast—PTGS1—hematopoietic system—sarcoma	0.00147	0.0153	CbGeAlD
Montelukast—SLCO2B1—liver—sarcoma	0.00146	0.0152	CbGeAlD
Montelukast—ALOX5—lymph node—sarcoma	0.00146	0.0151	CbGeAlD
Montelukast—PTGS1—connective tissue—sarcoma	0.00142	0.0147	CbGeAlD
Montelukast—PTGS1—smooth muscle tissue—sarcoma	0.0013	0.0135	CbGeAlD
Montelukast—PTGS1—skin of body—sarcoma	0.00128	0.0133	CbGeAlD
Montelukast—CYP3A4—hematopoietic system—sarcoma	0.00123	0.0128	CbGeAlD
Montelukast—SLCO2B1—lymph node—sarcoma	0.00112	0.0117	CbGeAlD
Montelukast—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00112	0.00302	CcSEcCtD
Montelukast—PTGS1—cardiac atrium—sarcoma	0.00112	0.0116	CbGeAlD
Montelukast—PTGS1—uterus—sarcoma	0.00111	0.0116	CbGeAlD
Montelukast—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00111	0.003	CcSEcCtD
Montelukast—Myalgia—Mitoxantrone—sarcoma	0.00111	0.00298	CcSEcCtD
Montelukast—Arthralgia—Mitoxantrone—sarcoma	0.00111	0.00298	CcSEcCtD
Montelukast—Paraesthesia—Thiotepa—sarcoma	0.00111	0.00298	CcSEcCtD
Montelukast—Anxiety—Mitoxantrone—sarcoma	0.00111	0.00297	CcSEcCtD
Montelukast—Somnolence—Thiotepa—sarcoma	0.00109	0.00295	CcSEcCtD
Montelukast—Anaphylactic shock—Vincristine—sarcoma	0.00109	0.00294	CcSEcCtD
Montelukast—Oedema—Vincristine—sarcoma	0.00109	0.00294	CcSEcCtD
Montelukast—Infection—Vincristine—sarcoma	0.00108	0.00292	CcSEcCtD
Montelukast—Dyspepsia—Thiotepa—sarcoma	0.00108	0.00292	CcSEcCtD
Montelukast—Nervous system disorder—Vincristine—sarcoma	0.00107	0.00288	CcSEcCtD
Montelukast—Thrombocytopenia—Vincristine—sarcoma	0.00107	0.00288	CcSEcCtD
Montelukast—Anaphylactic shock—Mitoxantrone—sarcoma	0.00106	0.00286	CcSEcCtD
Montelukast—Oedema—Mitoxantrone—sarcoma	0.00106	0.00286	CcSEcCtD
Montelukast—Gastrointestinal disorder—Thiotepa—sarcoma	0.00106	0.00286	CcSEcCtD
Montelukast—Fatigue—Thiotepa—sarcoma	0.00106	0.00286	CcSEcCtD
Montelukast—Infection—Mitoxantrone—sarcoma	0.00106	0.00284	CcSEcCtD
Montelukast—Fatigue—Dactinomycin—sarcoma	0.00105	0.00284	CcSEcCtD
Montelukast—Pain—Thiotepa—sarcoma	0.00105	0.00283	CcSEcCtD
Montelukast—Pain—Dactinomycin—sarcoma	0.00104	0.00281	CcSEcCtD
Montelukast—Muscle spasms—Etoposide—sarcoma	0.00104	0.0028	CcSEcCtD
Montelukast—Thrombocytopenia—Mitoxantrone—sarcoma	0.00104	0.0028	CcSEcCtD
Montelukast—Eczema—Doxorubicin—sarcoma	0.00104	0.00279	CcSEcCtD
Montelukast—Skin disorder—Mitoxantrone—sarcoma	0.00103	0.00278	CcSEcCtD
Montelukast—Gastrointestinal pain—Thiotepa—sarcoma	0.00101	0.00271	CcSEcCtD
Montelukast—Gastrointestinal pain—Dactinomycin—sarcoma	0.000999	0.00269	CcSEcCtD
Montelukast—CYP2C8—testis—sarcoma	0.000996	0.0103	CbGeAlD
Montelukast—Musculoskeletal discomfort—Vincristine—sarcoma	0.000995	0.00268	CcSEcCtD
Montelukast—Insomnia—Vincristine—sarcoma	0.000987	0.00266	CcSEcCtD
Montelukast—Paraesthesia—Vincristine—sarcoma	0.00098	0.00264	CcSEcCtD
Montelukast—Urticaria—Thiotepa—sarcoma	0.000978	0.00263	CcSEcCtD
Montelukast—PTGS1—tendon—sarcoma	0.000975	0.0101	CbGeAlD
Montelukast—Abdominal pain—Thiotepa—sarcoma	0.000973	0.00262	CcSEcCtD
Montelukast—Body temperature increased—Thiotepa—sarcoma	0.000973	0.00262	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000969	0.00261	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—sarcoma	0.000966	0.0026	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—sarcoma	0.000966	0.0026	CcSEcCtD
Montelukast—Paraesthesia—Mitoxantrone—sarcoma	0.000955	0.00257	CcSEcCtD
Montelukast—Cough—Etoposide—sarcoma	0.000945	0.00254	CcSEcCtD
Montelukast—Somnolence—Mitoxantrone—sarcoma	0.000945	0.00254	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vincristine—sarcoma	0.000942	0.00254	CcSEcCtD
Montelukast—CYP2C8—liver—sarcoma	0.000942	0.00977	CbGeAlD
Montelukast—Fatigue—Vincristine—sarcoma	0.000941	0.00253	CcSEcCtD
Montelukast—Convulsion—Etoposide—sarcoma	0.000939	0.00253	CcSEcCtD
Montelukast—Dyspepsia—Mitoxantrone—sarcoma	0.000936	0.00252	CcSEcCtD
Montelukast—Pain—Vincristine—sarcoma	0.000934	0.00251	CcSEcCtD
Montelukast—Fatigue—Mitoxantrone—sarcoma	0.000917	0.00247	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000916	0.00247	CcSEcCtD
Montelukast—Pain—Mitoxantrone—sarcoma	0.000909	0.00245	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000908	0.00244	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000908	0.00244	CcSEcCtD
Montelukast—Hypersensitivity—Thiotepa—sarcoma	0.000907	0.00244	CcSEcCtD
Montelukast—Nasopharyngitis—Epirubicin—sarcoma	0.000902	0.00243	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—sarcoma	0.0009	0.00242	CcSEcCtD
Montelukast—Gastrointestinal pain—Vincristine—sarcoma	0.000893	0.0024	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00089	0.00239	CcSEcCtD
Montelukast—Anaphylactic shock—Etoposide—sarcoma	0.000884	0.00238	CcSEcCtD
Montelukast—Asthenia—Thiotepa—sarcoma	0.000883	0.00238	CcSEcCtD
Montelukast—Infection—Etoposide—sarcoma	0.000879	0.00236	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—sarcoma	0.000877	0.00236	CcSEcCtD
Montelukast—Asthma—Epirubicin—sarcoma	0.000872	0.00235	CcSEcCtD
Montelukast—Influenza—Epirubicin—sarcoma	0.000872	0.00235	CcSEcCtD
Montelukast—Pruritus—Thiotepa—sarcoma	0.000871	0.00234	CcSEcCtD
Montelukast—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000869	0.00234	CcSEcCtD
Montelukast—Thrombocytopenia—Etoposide—sarcoma	0.000866	0.00233	CcSEcCtD
Montelukast—Eosinophilia—Epirubicin—sarcoma	0.000863	0.00232	CcSEcCtD
Montelukast—Abdominal pain—Vincristine—sarcoma	0.000863	0.00232	CcSEcCtD
Montelukast—Body temperature increased—Vincristine—sarcoma	0.000863	0.00232	CcSEcCtD
Montelukast—Skin disorder—Etoposide—sarcoma	0.000859	0.00231	CcSEcCtD
Montelukast—Pancreatitis—Epirubicin—sarcoma	0.000855	0.0023	CcSEcCtD
Montelukast—Urticaria—Mitoxantrone—sarcoma	0.000845	0.00227	CcSEcCtD
Montelukast—Diarrhoea—Thiotepa—sarcoma	0.000842	0.00227	CcSEcCtD
Montelukast—Abdominal pain—Mitoxantrone—sarcoma	0.00084	0.00226	CcSEcCtD
Montelukast—Body temperature increased—Mitoxantrone—sarcoma	0.00084	0.00226	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00084	0.00226	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00084	0.00226	CcSEcCtD
Montelukast—Bronchitis—Epirubicin—sarcoma	0.000838	0.00226	CcSEcCtD
Montelukast—CYP2C9—liver—sarcoma	0.000836	0.00868	CbGeAlD
Montelukast—Diarrhoea—Dactinomycin—sarcoma	0.000836	0.00225	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—sarcoma	0.000834	0.00225	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000823	0.00222	CcSEcCtD
Montelukast—Dizziness—Thiotepa—sarcoma	0.000814	0.00219	CcSEcCtD
Montelukast—Upper respiratory tract infection—Epirubicin—sarcoma	0.00081	0.00218	CcSEcCtD
Montelukast—PTGS1—testis—sarcoma	0.000808	0.00838	CbGeAlD
Montelukast—Influenza—Doxorubicin—sarcoma	0.000807	0.00217	CcSEcCtD
Montelukast—Asthma—Doxorubicin—sarcoma	0.000807	0.00217	CcSEcCtD
Montelukast—Hypersensitivity—Vincristine—sarcoma	0.000804	0.00216	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—sarcoma	0.000799	0.00215	CcSEcCtD
Montelukast—Paraesthesia—Etoposide—sarcoma	0.000794	0.00214	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—sarcoma	0.000791	0.00213	CcSEcCtD
Montelukast—Somnolence—Etoposide—sarcoma	0.000786	0.00212	CcSEcCtD
Montelukast—Hypersensitivity—Mitoxantrone—sarcoma	0.000783	0.00211	CcSEcCtD
Montelukast—Asthenia—Vincristine—sarcoma	0.000783	0.00211	CcSEcCtD
Montelukast—Vomiting—Thiotepa—sarcoma	0.000783	0.00211	CcSEcCtD
Montelukast—Pneumonia—Epirubicin—sarcoma	0.000782	0.0021	CcSEcCtD
Montelukast—Drowsiness—Epirubicin—sarcoma	0.000777	0.00209	CcSEcCtD
Montelukast—Infestation—Epirubicin—sarcoma	0.000777	0.00209	CcSEcCtD
Montelukast—Infestation NOS—Epirubicin—sarcoma	0.000777	0.00209	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—sarcoma	0.000777	0.00209	CcSEcCtD
Montelukast—Rash—Thiotepa—sarcoma	0.000776	0.00209	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—sarcoma	0.000776	0.00209	CcSEcCtD
Montelukast—Dermatitis—Thiotepa—sarcoma	0.000775	0.00209	CcSEcCtD
Montelukast—Headache—Thiotepa—sarcoma	0.000771	0.00208	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000771	0.00207	CcSEcCtD
Montelukast—Rash—Dactinomycin—sarcoma	0.00077	0.00207	CcSEcCtD
Montelukast—Gastrointestinal disorder—Etoposide—sarcoma	0.000763	0.00205	CcSEcCtD
Montelukast—Asthenia—Mitoxantrone—sarcoma	0.000763	0.00205	CcSEcCtD
Montelukast—Fatigue—Etoposide—sarcoma	0.000762	0.00205	CcSEcCtD
Montelukast—Neuropathy peripheral—Epirubicin—sarcoma	0.000762	0.00205	CcSEcCtD
Montelukast—Jaundice—Epirubicin—sarcoma	0.000758	0.00204	CcSEcCtD
Montelukast—Pain—Etoposide—sarcoma	0.000756	0.00204	CcSEcCtD
Montelukast—Conjunctivitis—Epirubicin—sarcoma	0.000755	0.00203	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00075	0.00202	CcSEcCtD
Montelukast—Diarrhoea—Vincristine—sarcoma	0.000747	0.00201	CcSEcCtD
Montelukast—Hepatobiliary disease—Epirubicin—sarcoma	0.000735	0.00198	CcSEcCtD
Montelukast—Epistaxis—Epirubicin—sarcoma	0.000733	0.00197	CcSEcCtD
Montelukast—Nausea—Thiotepa—sarcoma	0.000731	0.00197	CcSEcCtD
Montelukast—Sinusitis—Epirubicin—sarcoma	0.000729	0.00196	CcSEcCtD
Montelukast—Diarrhoea—Mitoxantrone—sarcoma	0.000727	0.00196	CcSEcCtD
Montelukast—Nausea—Dactinomycin—sarcoma	0.000726	0.00195	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—sarcoma	0.000723	0.00195	CcSEcCtD
Montelukast—Gastrointestinal pain—Etoposide—sarcoma	0.000723	0.00195	CcSEcCtD
Montelukast—Dizziness—Vincristine—sarcoma	0.000722	0.00194	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—sarcoma	0.000719	0.00194	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—sarcoma	0.000719	0.00194	CcSEcCtD
Montelukast—Infestation—Doxorubicin—sarcoma	0.000719	0.00194	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000713	0.00192	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—sarcoma	0.000705	0.0019	CcSEcCtD
Montelukast—Urticaria—Etoposide—sarcoma	0.000703	0.00189	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—sarcoma	0.000701	0.00189	CcSEcCtD
Montelukast—Rhinitis—Epirubicin—sarcoma	0.000699	0.00188	CcSEcCtD
Montelukast—Abdominal pain—Etoposide—sarcoma	0.000699	0.00188	CcSEcCtD
Montelukast—Body temperature increased—Etoposide—sarcoma	0.000699	0.00188	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—sarcoma	0.000699	0.00188	CcSEcCtD
Montelukast—Hepatitis—Epirubicin—sarcoma	0.000698	0.00188	CcSEcCtD
Montelukast—Hypoaesthesia—Epirubicin—sarcoma	0.000694	0.00187	CcSEcCtD
Montelukast—Vomiting—Vincristine—sarcoma	0.000694	0.00187	CcSEcCtD
Montelukast—Pharyngitis—Epirubicin—sarcoma	0.000692	0.00186	CcSEcCtD
Montelukast—Urinary tract disorder—Epirubicin—sarcoma	0.000689	0.00185	CcSEcCtD
Montelukast—Rash—Vincristine—sarcoma	0.000688	0.00185	CcSEcCtD
Montelukast—Dermatitis—Vincristine—sarcoma	0.000688	0.00185	CcSEcCtD
Montelukast—Connective tissue disorder—Epirubicin—sarcoma	0.000686	0.00185	CcSEcCtD
Montelukast—Urethral disorder—Epirubicin—sarcoma	0.000684	0.00184	CcSEcCtD
Montelukast—Headache—Vincristine—sarcoma	0.000684	0.00184	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—sarcoma	0.00068	0.00183	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—sarcoma	0.000678	0.00183	CcSEcCtD
Montelukast—Vomiting—Mitoxantrone—sarcoma	0.000676	0.00182	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—sarcoma	0.000675	0.00182	CcSEcCtD
Montelukast—Rash—Mitoxantrone—sarcoma	0.00067	0.0018	CcSEcCtD
Montelukast—Dermatitis—Mitoxantrone—sarcoma	0.00067	0.0018	CcSEcCtD
Montelukast—Headache—Mitoxantrone—sarcoma	0.000666	0.00179	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—sarcoma	0.00066	0.00178	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—sarcoma	0.000652	0.00175	CcSEcCtD
Montelukast—Nausea—Vincristine—sarcoma	0.000648	0.00175	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—sarcoma	0.000648	0.00174	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—sarcoma	0.000647	0.00174	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—sarcoma	0.000646	0.00174	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—sarcoma	0.000642	0.00173	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—sarcoma	0.000641	0.00172	CcSEcCtD
Montelukast—CYP3A4—liver—sarcoma	0.000638	0.00662	CbGeAlD
Montelukast—Urinary tract disorder—Doxorubicin—sarcoma	0.000638	0.00172	CcSEcCtD
Montelukast—Asthenia—Etoposide—sarcoma	0.000634	0.00171	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—sarcoma	0.000634	0.00171	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—sarcoma	0.000633	0.0017	CcSEcCtD
Montelukast—Nausea—Mitoxantrone—sarcoma	0.000631	0.0017	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—sarcoma	0.00063	0.0017	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—sarcoma	0.000629	0.00169	CcSEcCtD
Montelukast—Pruritus—Etoposide—sarcoma	0.000626	0.00168	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—sarcoma	0.000611	0.00165	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—sarcoma	0.00061	0.00164	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—sarcoma	0.000605	0.00163	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—sarcoma	0.000599	0.00161	CcSEcCtD
Montelukast—PTGS1—lymph node—sarcoma	0.000585	0.00608	CbGeAlD
Montelukast—Dizziness—Etoposide—sarcoma	0.000585	0.00157	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—sarcoma	0.000584	0.00157	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—sarcoma	0.000583	0.00157	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—sarcoma	0.000582	0.00157	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—sarcoma	0.000566	0.00152	CcSEcCtD
Montelukast—Vomiting—Etoposide—sarcoma	0.000562	0.00151	CcSEcCtD
Montelukast—Agitation—Epirubicin—sarcoma	0.000558	0.0015	CcSEcCtD
Montelukast—Rash—Etoposide—sarcoma	0.000558	0.0015	CcSEcCtD
Montelukast—Dermatitis—Etoposide—sarcoma	0.000557	0.0015	CcSEcCtD
Montelukast—Headache—Etoposide—sarcoma	0.000554	0.00149	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—sarcoma	0.00054	0.00145	CcSEcCtD
Montelukast—Palpitations—Epirubicin—sarcoma	0.000537	0.00144	CcSEcCtD
Montelukast—Cough—Epirubicin—sarcoma	0.00053	0.00143	CcSEcCtD
Montelukast—Convulsion—Epirubicin—sarcoma	0.000526	0.00142	CcSEcCtD
Montelukast—Nausea—Etoposide—sarcoma	0.000525	0.00141	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—sarcoma	0.000517	0.00139	CcSEcCtD
Montelukast—Myalgia—Epirubicin—sarcoma	0.000517	0.00139	CcSEcCtD
Montelukast—Agitation—Doxorubicin—sarcoma	0.000516	0.00139	CcSEcCtD
Montelukast—Anxiety—Epirubicin—sarcoma	0.000515	0.00139	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000514	0.00138	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—sarcoma	0.000497	0.00134	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—sarcoma	0.000496	0.00133	CcSEcCtD
Montelukast—Oedema—Epirubicin—sarcoma	0.000496	0.00133	CcSEcCtD
Montelukast—Infection—Epirubicin—sarcoma	0.000492	0.00133	CcSEcCtD
Montelukast—Cough—Doxorubicin—sarcoma	0.00049	0.00132	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—sarcoma	0.000487	0.00131	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—sarcoma	0.000486	0.00131	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—sarcoma	0.000485	0.00131	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—sarcoma	0.000481	0.0013	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—sarcoma	0.000478	0.00129	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—sarcoma	0.000478	0.00129	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—sarcoma	0.000477	0.00128	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000475	0.00128	CcSEcCtD
Montelukast—Oedema—Doxorubicin—sarcoma	0.000459	0.00123	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—sarcoma	0.000459	0.00123	CcSEcCtD
Montelukast—Infection—Doxorubicin—sarcoma	0.000456	0.00123	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000452	0.00122	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—sarcoma	0.00045	0.00121	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—sarcoma	0.000449	0.00121	CcSEcCtD
Montelukast—Insomnia—Epirubicin—sarcoma	0.000448	0.00121	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—sarcoma	0.000446	0.0012	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—sarcoma	0.000445	0.0012	CcSEcCtD
Montelukast—Somnolence—Epirubicin—sarcoma	0.000441	0.00119	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—sarcoma	0.000436	0.00117	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—sarcoma	0.000428	0.00115	CcSEcCtD
Montelukast—Fatigue—Epirubicin—sarcoma	0.000427	0.00115	CcSEcCtD
Montelukast—Pain—Epirubicin—sarcoma	0.000424	0.00114	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000418	0.00112	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—sarcoma	0.000415	0.00112	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—sarcoma	0.000412	0.00111	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—sarcoma	0.000408	0.0011	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—sarcoma	0.000405	0.00109	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—sarcoma	0.000404	0.00109	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000396	0.00107	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—sarcoma	0.000395	0.00106	CcSEcCtD
Montelukast—Urticaria—Epirubicin—sarcoma	0.000394	0.00106	CcSEcCtD
Montelukast—Pain—Doxorubicin—sarcoma	0.000392	0.00106	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—sarcoma	0.000392	0.00105	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—sarcoma	0.000392	0.00105	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—sarcoma	0.000375	0.00101	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—sarcoma	0.000365	0.000983	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—sarcoma	0.000364	0.000981	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—sarcoma	0.000363	0.000976	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—sarcoma	0.000363	0.000976	CcSEcCtD
Montelukast—Asthenia—Epirubicin—sarcoma	0.000356	0.000957	CcSEcCtD
Montelukast—Pruritus—Epirubicin—sarcoma	0.000351	0.000944	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—sarcoma	0.000339	0.000913	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—sarcoma	0.000338	0.00091	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—sarcoma	0.000329	0.000886	CcSEcCtD
Montelukast—Dizziness—Epirubicin—sarcoma	0.000328	0.000882	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—sarcoma	0.000324	0.000873	CcSEcCtD
Montelukast—Vomiting—Epirubicin—sarcoma	0.000315	0.000848	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—sarcoma	0.000314	0.000845	CcSEcCtD
Montelukast—Rash—Epirubicin—sarcoma	0.000313	0.000841	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—sarcoma	0.000312	0.00084	CcSEcCtD
Montelukast—Headache—Epirubicin—sarcoma	0.000311	0.000836	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—sarcoma	0.000303	0.000816	CcSEcCtD
Montelukast—Nausea—Epirubicin—sarcoma	0.000294	0.000792	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—sarcoma	0.000292	0.000785	CcSEcCtD
Montelukast—Rash—Doxorubicin—sarcoma	0.000289	0.000778	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—sarcoma	0.000289	0.000778	CcSEcCtD
Montelukast—Headache—Doxorubicin—sarcoma	0.000287	0.000773	CcSEcCtD
Montelukast—Nausea—Doxorubicin—sarcoma	0.000272	0.000733	CcSEcCtD
